A number of PPAR α/γ dual agonists have been recently developed and others are being evaluated for their effects on insulin resistance in animal models and in type 2 diabetes patients [11], [12], [13], [14], [15], [16]. This evidence concerns the gene PPARA and Insulin resistance.